Cargando…
Interstitial lung disease before and after COVID-19: a double threat?
Pre-existing ILD and pulmonary fibrosis increases the risk to manifest severe COVID-19. Residual interstitial lung changes and sequelae have been observed in COVID-19 survivors. A closer and standardised long-term follow-up of these patients is needed. https://bit.ly/3jWBPCG
Autores principales: | Valenzuela, Claudia, Waterer, Grant, Raghu, Ganesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637181/ https://www.ncbi.nlm.nih.gov/pubmed/34857587 http://dx.doi.org/10.1183/13993003.01956-2021 |
Ejemplares similares
-
Cryobiopsy for Interstitial Lung Disease: The Heat Is On
por: Raghu, Ganesh, et al.
Publicado: (2019) -
Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registry
por: Raghu, Ganesh, et al.
Publicado: (2016) -
Lung transplantation for interstitial lung disease
por: Kapnadak, Siddhartha G., et al.
Publicado: (2021) -
Understanding COVID-19 Pathophysiology: What Defines Progress?
por: Waterer, Grant
Publicado: (2021) -
Lungs after COVID-19: Evolving Knowledge of Post–COVID-19 Interstitial Lung Disease
por: Aronson, Kerri I., et al.
Publicado: (2021)